Cargando…

Cancer as a Metabolic Disorder

Cancer has long been considered a genetic disease characterized by a myriad of mutations that drive cancer progression. Recent accumulating evidence indicates that the dysregulated metabolism in cancer cells is more than a hallmark of cancer but may be the underlying cause of the tumor. Most of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gyamfi, Jones, Kim, Jinyoung, Choi, Junjeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835572/
https://www.ncbi.nlm.nih.gov/pubmed/35163079
http://dx.doi.org/10.3390/ijms23031155
_version_ 1784649466623557632
author Gyamfi, Jones
Kim, Jinyoung
Choi, Junjeong
author_facet Gyamfi, Jones
Kim, Jinyoung
Choi, Junjeong
author_sort Gyamfi, Jones
collection PubMed
description Cancer has long been considered a genetic disease characterized by a myriad of mutations that drive cancer progression. Recent accumulating evidence indicates that the dysregulated metabolism in cancer cells is more than a hallmark of cancer but may be the underlying cause of the tumor. Most of the well-characterized oncogenes or tumor suppressor genes function to sustain the altered metabolic state in cancer. Here, we review evidence supporting the altered metabolic state in cancer including key alterations in glucose, glutamine, and fatty acid metabolism. Unlike genetic alterations that do not occur in all cancer types, metabolic alterations are more common among cancer subtypes and across cancers. Recognizing cancer as a metabolic disorder could unravel key diagnostic and treatments markers that can impact approaches used in cancer management.
format Online
Article
Text
id pubmed-8835572
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88355722022-02-12 Cancer as a Metabolic Disorder Gyamfi, Jones Kim, Jinyoung Choi, Junjeong Int J Mol Sci Review Cancer has long been considered a genetic disease characterized by a myriad of mutations that drive cancer progression. Recent accumulating evidence indicates that the dysregulated metabolism in cancer cells is more than a hallmark of cancer but may be the underlying cause of the tumor. Most of the well-characterized oncogenes or tumor suppressor genes function to sustain the altered metabolic state in cancer. Here, we review evidence supporting the altered metabolic state in cancer including key alterations in glucose, glutamine, and fatty acid metabolism. Unlike genetic alterations that do not occur in all cancer types, metabolic alterations are more common among cancer subtypes and across cancers. Recognizing cancer as a metabolic disorder could unravel key diagnostic and treatments markers that can impact approaches used in cancer management. MDPI 2022-01-21 /pmc/articles/PMC8835572/ /pubmed/35163079 http://dx.doi.org/10.3390/ijms23031155 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gyamfi, Jones
Kim, Jinyoung
Choi, Junjeong
Cancer as a Metabolic Disorder
title Cancer as a Metabolic Disorder
title_full Cancer as a Metabolic Disorder
title_fullStr Cancer as a Metabolic Disorder
title_full_unstemmed Cancer as a Metabolic Disorder
title_short Cancer as a Metabolic Disorder
title_sort cancer as a metabolic disorder
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835572/
https://www.ncbi.nlm.nih.gov/pubmed/35163079
http://dx.doi.org/10.3390/ijms23031155
work_keys_str_mv AT gyamfijones cancerasametabolicdisorder
AT kimjinyoung cancerasametabolicdisorder
AT choijunjeong cancerasametabolicdisorder